Structures by: Jiang X. J.
Total: 24
C2.24H2.15N0.24O0.21
C2.24H2.15N0.24O0.21
Org. Biomol. Chem. (2017)
a=13.255(2)Å b=15.682(3)Å c=17.830(3)Å
α=87.669(10)° β=72.107(9)° γ=70.902(9)°
C36H28BCl3N6O4
C36H28BCl3N6O4
Organic & biomolecular chemistry (2007) 5, 24 3987-3992
a=8.8675(12)Å b=12.5714(17)Å c=16.873(2)Å
α=77.372(3)° β=85.404(3)° γ=69.451(2)°
C24H29BrN2O4
C24H29BrN2O4
Org. Biomol. Chem. (2017)
a=7.8755(4)Å b=11.9538(6)Å c=13.5136(8)Å
α=66.584(3)° β=88.943(3)° γ=81.445(3)°
C19H20CoF6O8
C19H20CoF6O8
CrystEngComm (2009) 11, 5 855
a=6.877(5)Å b=27.252(18)Å c=11.664(8)Å
α=90.00° β=90.052(3)° γ=90.00°
C19H20F6NiO8
C19H20F6NiO8
CrystEngComm (2009) 11, 5 855
a=6.8247(5)Å b=27.1975(19)Å c=11.5922(8)Å
α=90.00° β=90.0350(10)° γ=90.00°
C19H20F6MnO8
C19H20F6MnO8
CrystEngComm (2009) 11, 5 855
a=6.942(3)Å b=27.341(11)Å c=11.782(5)Å
α=90.00° β=90.095(7)° γ=90.00°
C17H10CuF6O5
C17H10CuF6O5
CrystEngComm (2009) 11, 5 855
a=12.6969(7)Å b=6.9692(4)Å c=23.6089(9)Å
α=90.00° β=118.499(2)° γ=90.00°
C35H34F12O16Zn2
C35H34F12O16Zn2
CrystEngComm (2009) 11, 5 855
a=12.9861(17)Å b=12.1989(16)Å c=13.2626(17)Å
α=90.00° β=95.072(2)° γ=90.00°
C20H16N6O4
C20H16N6O4
CrystEngComm (2009) 11, 3 454
a=18.5354(9)Å b=6.5819(3)Å c=14.7391(7)Å
α=90.00° β=91.9870(10)° γ=90.00°
C20H16N6O4
C20H16N6O4
CrystEngComm (2009) 11, 3 454
a=6.255(2)Å b=7.187(2)Å c=20.272(4)Å
α=83.78(3)° β=86.62(3)° γ=79.03(2)°
C20H17N7O4
C20H17N7O4
CrystEngComm (2009) 11, 3 454
a=17.5638(13)Å b=7.3710(6)Å c=14.4866(11)Å
α=90.00° β=93.0100(10)° γ=90.00°
C21H20N6O8
C21H20N6O8
CrystEngComm (2009) 11, 3 454
a=7.3454(7)Å b=37.522(3)Å c=8.5441(8)Å
α=90.00° β=113.3500(10)° γ=90.00°
C20H20N6O9S
C20H20N6O9S
CrystEngComm (2009) 11, 3 454
a=7.1997(8)Å b=21.912(2)Å c=14.1960(15)Å
α=90.00° β=98.1160(10)° γ=90.00°
C34H18Ag2F12O8
C34H18Ag2F12O8
CrystEngComm (2009) 11, 5 855
a=30.984(6)Å b=30.984(6)Å c=6.7681(14)Å
α=90.00° β=90.00° γ=90.00°
C34H32N4O5
C34H32N4O5
Dalton transactions (Cambridge, England : 2003) (2014) 43, 33 12624-12632
a=14.9309(19)Å b=9.0628(10)Å c=27.435(6)Å
α=90.00° β=94.605(14)° γ=90.00°
C68H66AlClN8O12
C68H66AlClN8O12
Dalton transactions (Cambridge, England : 2003) (2014) 43, 33 12624-12632
a=23.791(3)Å b=18.3258(18)Å c=15.0315(14)Å
α=90.00° β=102.654(11)° γ=90.00°
C71H71CdN9O12
C71H71CdN9O12
Dalton transactions (Cambridge, England : 2003) (2014) 43, 33 12624-12632
a=9.6254(6)Å b=17.1742(12)Å c=22.7259(19)Å
α=102.047(7)° β=98.682(6)° γ=106.138(6)°
C82H94N12O20Pb2,2(NO3),8(H2O)
C82H94N12O20Pb2,2(NO3),8(H2O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 39 17326-17334
a=12.1829(4)Å b=14.0906(8)Å c=14.9798(6)Å
α=63.766(5)° β=77.410(3)° γ=78.245(4)°
4-Amino-3,5-bis(2-pyridyl)-4<i>H</i>-1,2,4-triazole--benzene-1,2,3- tricarboxylic acid--water (1/1/2)
C12H10N6,C9H6O6,2(H2O)
Acta Crystallographica Section E (2010) 66, 5 o1075-o1076
a=8.4266(10)Å b=8.6317(10)Å c=15.7318(18)Å
α=75.152(12)° β=77.179(12)° γ=88.417(13)°
<i>catena</i>-Poly[[silver(I)-μ-4,4-bipyridine-κ^2^<i>N</i>:<i>N</i>'] 4-[2-(4-carboxyphenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]benzoate]
C10H8AgN2,C17H9F6O4
Acta Crystallographica Section E (2012) 68, 5 m613-m614
a=16.434(7)Å b=11.436(5)Å c=14.320(6)Å
α=90.00° β=104.310(7)° γ=90.00°
C36H20CuN6O8
C36H20CuN6O8
Crystal Growth & Design (2015) 15, 2 687
a=12.4110(11)Å b=19.5709(17)Å c=15.6611(13)Å
α=90.00° β=90.00° γ=90.00°
C36H24N6O8Zn
C36H24N6O8Zn
Crystal Growth & Design (2015) 15, 2 687
a=7.9371(16)Å b=15.359(3)Å c=14.644(3)Å
α=90.00° β=103.76(3)° γ=90.00°
C36H25CoN6O8.50
C36H25CoN6O8.50
Crystal Growth & Design (2015) 15, 2 687
a=8.026(4)Å b=15.446(7)Å c=14.588(7)Å
α=90.00° β=103.873(8)° γ=90.00°
C74H76Cd6N30O39
C74H76Cd6N30O39
Inorganic chemistry (2014) 141202101910005
a=11.9248(17)Å b=13.2788(19)Å c=16.859(2)Å
α=93.849(12)° β=93.549(11)° γ=105.653(13)°